CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Hematologic Malignancies » Leukemia and Lymphoma

RESEARCH REPORT 

Early Life Non-Hodgkin Lymphoma Risk Factors Identified

By Anna Azvolinsky, PhD | May 24, 2012

A new study has identified independent risk factors for the development of non-Hodgkin lymphoma (NHL) including high fetal growth, older age of the mother, low birth order, and male sex. A family history of NHL in either parent or sibling was found to be the strongest risk factor. Male sex was only associated with NHL risk up to age 15, but not for later-onset NHL. Gestation age at birth, twinning, age of the father, and parental education were not associated with NHL risk. The large national cohort study is published in the Journal of the National Cancer Institute.

Cutaneous anaplastic large-cell lymphoma, a type of NHL, on histology

Lead author Casey Crump, department of medicine at Stanford University in California, and colleagues aimed to identify risk factors for NHL as childhood and adolescent NHL rates have steadily increased over the last 50 years. NHL rates almost doubled between 1975 and 2000 in the United States. Better screening methods only partially explain the rise in numbers and perinatal factors have been proposed to contribute to the risk.

(MORE: Follicular Lymphoma: Getting Results in a Tough-to-Treat Disease)

The cohort consisted of more than 3.5 million people born in Sweden between 1973 and 2008. The subjects were followed for NHL incidence until 2009. Data such as perinatal and family characteristics, and NHL diagnosis timing were obtained through national birth and cancer registries. The study authors found that both genetics and in utero conditions contributed independently to NHL development. There were 936 NHL cases identified in the cohort. Sweden has detailed and complete national registries facilitating a study of this scale and allowing for a robust analysis of early life development and risk factors.

“We identified multiple risk factors for NHL in early life, which can help shed light on underlying causes,” said Casey Crump.  According to Crump, one of the most surprising findings was the link between high fetal growth and NHL. “Most previous data have shown no effect. But those data were derived mainly from case-control studies of birth weight and may not have had adequate specificity or control for confounding to observe an effect with fetal growth,” explained Crump. While the mechanism is not well established, Crump speculated it may involve increased levels of fetal growth factors that can enhance tumor growth.

A second surprising result, according to Crump, is the association of low birth order and NHL. “This was in contrast to various smaller studies and is consistent with the ‘delayed exposure hypothesis,’” said Crump. This hypothesis postulates that delayed infectious exposures, resulting from an absence of older siblings, can result in impaired maturation of the immune system which could predispose a child to develop NHL.

The higher incidence of NHL among males is not explained well, said Crump. He added that he is not aware of a diagnosis bias that could potentially explain the skew in statistics.
NHL has many different origins and can involve genetic factors, the Epstein-Barr virus, immunodeficiency disorders, and environmental factors, among others. Because of the climb in NHL diagnoses in children and young adults, there is an interest in understanding the perinatal risk factors to better identify high-risk infants to provide better early detection and treatment.

A limitation of the study is the missing environmental risk factors such as pollutants, contaminants, and radiation that likely vary by geography. An accompanying editorial by William F. Anderson, MD, MPH, and Benjamin Emmanuel, MPH, the Division of Cancer Epidemiology and Genetics at the National Cancer Institute, highlights this limitation but emphasizes the importance and scale of the study which maximizes the ability to generalize the conclusions to different populations.

“Our findings suggested that there are important unmeasured environmental factors, which indeed vary in different places and will need further investigation in different populations,” said Crump. He added that the underlying mechanism for early-onset NHL are likely to be similar among industrialized countries in North America and Europe.

“We hope that our findings will lead to additional research into environmental and genetic risk factors for NHL in this population and others,” said Crump. “Pooled studies of sibling pairs would be a helpful next step to elucidate gene–environment interactions.”

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

More On This Topic

Diffuse Large B-cell Lymphoma Mimics Other Disorders

New Gene Test Zones in on Burkitt Lymphoma

Multifaceted Aggressive B-cell Lymphoma Calls for Targeted Therapy

Early Life Non-Hodgkin Lymphoma Risk Factors Identified

Follicular Lymphoma: Getting Results in a Tough-to-Treat Disease






 
RELATED CONTENT

Radiotherapy Is NOT Essential to Cure Diffuse Large B-Cell Non-Hodgkin Lymphoma
ONCOLOGY,  May 15, 2013
Making Good Results Even Better: The Evolving Role of Radiotherapy in Patients With Early Diffuse Large B-Cell Lymphoma
ONCOLOGY,  May 15, 2013
EPOCH-Rituximab Therapy Obviates Need for Radiotherapy in B-Cell Lymphoma
April 23, 2013
When Can R-CHOP Not Be Used in an Elderly Patient?
ONCOLOGY,  February 15, 2013
Diffuse Large B-Cell Lymphoma in the Elderly: Leaving Our Old Way(s) Behind?
ONCOLOGY,  February 15, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy